| 287 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 535.4 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 6.244 | ug/mL | CD86, EC120 | Dermal | - | NTP_ICE_skin_sensitization |
| 79.007 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 80.86 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 427 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| >200 | ug/mL | CV70 | Dermal | - | NTP_ICE_skin_sensitization |
| 563.6 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 1000 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| =2.45 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 87.3 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 93.5 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 12.4 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 33.9 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 49.85 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 63.7 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 7.06 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 10.6 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 12.65 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 13.32 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 14 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 35.56 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 42 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 44.45 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 46.71 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 47.03 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 49.74 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 54.6 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 54.66 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 57.41 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 59.93 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 67.79 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 70.31 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 78.2 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 81.5 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 89.3 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 98.36 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 112.2 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| <120.56 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 123.23 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 128.5 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 28 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 253.369 | uM | EC3 | Dermal | - | NTP_ICE_skin_sensitization |
| 7BK5G69305 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 7BK5G69305 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 7BK5G69305 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 7BK5G69305 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| >300 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 639.2 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 667.39 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |